Cargando…
Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches
In addition to deoxynivalenol (DON), acetylated derivatives, i.e., 3-acetyl and 15-acetyldexynivalenol (or 3/15ADON), are present in cereals leading to exposure to these mycotoxins. Animal and human studies suggest that 3/15ADON are converted into DON after their ingestion through hydrolysis of the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999848/ https://www.ncbi.nlm.nih.gov/pubmed/27483321 http://dx.doi.org/10.3390/toxins8080232 |
_version_ | 1782450173124804608 |
---|---|
author | Ajandouz, El Hassan Berdah, Stéphane Moutardier, Vincent Bege, Thierry Birnbaum, David Jérémie Perrier, Josette Di Pasquale, Eric Maresca, Marc |
author_facet | Ajandouz, El Hassan Berdah, Stéphane Moutardier, Vincent Bege, Thierry Birnbaum, David Jérémie Perrier, Josette Di Pasquale, Eric Maresca, Marc |
author_sort | Ajandouz, El Hassan |
collection | PubMed |
description | In addition to deoxynivalenol (DON), acetylated derivatives, i.e., 3-acetyl and 15-acetyldexynivalenol (or 3/15ADON), are present in cereals leading to exposure to these mycotoxins. Animal and human studies suggest that 3/15ADON are converted into DON after their ingestion through hydrolysis of the acetyl moiety, the site(s) of such deacetylation being still uncharacterized. We used in vitro and ex vivo approaches to study the deacetylation of 3/15ADON by enzymes and cells/tissues present on their way from the food matrix to the blood in humans. We found that luminal deacetylation by digestive enzymes and bacteria is limited. Using human cells, tissues and S9 fractions, we were able to demonstrate that small intestine and liver possess strong deacetylation capacity compared to colon and kidneys. Interestingly, in most cases, deacetylation was more efficient for 3ADON than 15ADON. Although we initially thought that carboxylesterases (CES) could be responsible for the deacetylation of 3/15ADON, the use of pure human CES1/2 and of CES inhibitor demonstrated that CES are not involved. Taken together, our original model system allowed us to identify the small intestine and the liver as the main site of deacetylation of ingested 3/15ADON in humans. |
format | Online Article Text |
id | pubmed-4999848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-49998482016-09-01 Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches Ajandouz, El Hassan Berdah, Stéphane Moutardier, Vincent Bege, Thierry Birnbaum, David Jérémie Perrier, Josette Di Pasquale, Eric Maresca, Marc Toxins (Basel) Article In addition to deoxynivalenol (DON), acetylated derivatives, i.e., 3-acetyl and 15-acetyldexynivalenol (or 3/15ADON), are present in cereals leading to exposure to these mycotoxins. Animal and human studies suggest that 3/15ADON are converted into DON after their ingestion through hydrolysis of the acetyl moiety, the site(s) of such deacetylation being still uncharacterized. We used in vitro and ex vivo approaches to study the deacetylation of 3/15ADON by enzymes and cells/tissues present on their way from the food matrix to the blood in humans. We found that luminal deacetylation by digestive enzymes and bacteria is limited. Using human cells, tissues and S9 fractions, we were able to demonstrate that small intestine and liver possess strong deacetylation capacity compared to colon and kidneys. Interestingly, in most cases, deacetylation was more efficient for 3ADON than 15ADON. Although we initially thought that carboxylesterases (CES) could be responsible for the deacetylation of 3/15ADON, the use of pure human CES1/2 and of CES inhibitor demonstrated that CES are not involved. Taken together, our original model system allowed us to identify the small intestine and the liver as the main site of deacetylation of ingested 3/15ADON in humans. MDPI 2016-07-28 /pmc/articles/PMC4999848/ /pubmed/27483321 http://dx.doi.org/10.3390/toxins8080232 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ajandouz, El Hassan Berdah, Stéphane Moutardier, Vincent Bege, Thierry Birnbaum, David Jérémie Perrier, Josette Di Pasquale, Eric Maresca, Marc Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
title | Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
title_full | Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
title_fullStr | Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
title_full_unstemmed | Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
title_short | Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
title_sort | hydrolytic fate of 3/15-acetyldeoxynivalenol in humans: specific deacetylation by the small intestine and liver revealed using in vitro and ex vivo approaches |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999848/ https://www.ncbi.nlm.nih.gov/pubmed/27483321 http://dx.doi.org/10.3390/toxins8080232 |
work_keys_str_mv | AT ajandouzelhassan hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT berdahstephane hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT moutardiervincent hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT begethierry hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT birnbaumdavidjeremie hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT perrierjosette hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT dipasqualeeric hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches AT marescamarc hydrolyticfateof315acetyldeoxynivalenolinhumansspecificdeacetylationbythesmallintestineandliverrevealedusinginvitroandexvivoapproaches |